22Nw, LP has bought stock on 7 days since Apr 2019

22NW, LP is a company, specifically an investment limited partnership that has filed as a 10% beneficial owner of STRATA Skin Sciences, Inc. (NASDAQ: SSKN).( As disclosed in insider trading records, 22NW, LP—acting through 22NW Fund, LP—has accumulated a significant position in STRATA common stock, reported at over 3.5 million shares in a purchase transaction that established it as a 10% owner.( This level of ownership classifies 22NW, LP as a corporate insider under U.S. securities regulations and reflects an active investment role in the healthcare and medical technology sector.(

22NW, LP operates as an investment vehicle rather than an operating business, focusing on equity ownership stakes such as its position in STRATA Skin Sciences, a dermatology-focused medical technology company.( Public filings identify it in the context of insider trading and ownership reports, with transactions recorded under the name “22NW, LP By: 22NW Fund, LP,” indicating a fund structure with a general partner or managing entity overseeing investment decisions.( Specific details on the firm’s broader history, strategy, and leadership are not provided in the available STRATA-related insider trading disclosures, but its designation as a 10% owner underscores its role as a significant institutional or hedge fund–style investor in the company.(

Written by Perplexity from public sources.